John Kilichowski
Stock Analyst
(n/a)
# 4,650
Out of 4,650 analysts
7
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Kilichowski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADC Agree Realty | Maintains: Overweight | $80 → $79 | $76.02 | +3.92% | 2 | Nov 4, 2024 | |
| FVR FrontView REIT | Initiates: Overweight | $22 | $18.97 | +15.97% | 1 | Oct 28, 2024 | |
| NNN NNN REIT | Assumes: Equal-Weight | $47 → $50 | $42.94 | +16.44% | 1 | Oct 1, 2024 | |
| VTR Ventas | Assumes: Overweight | $61 → $71 | $64.84 | +9.50% | 1 | Oct 1, 2024 | |
| SBRA Sabra Health Care REIT | Assumes: Overweight | $16 → $20 | $19.67 | +1.68% | 1 | Oct 1, 2024 | |
| NHI National Health Investors | Assumes: Equal-Weight | $81 → $86 | $81.09 | +6.06% | 1 | Oct 1, 2024 |
Agree Realty
Nov 4, 2024
Maintains: Overweight
Price Target: $80 → $79
Current: $76.02
Upside: +3.92%
FrontView REIT
Oct 28, 2024
Initiates: Overweight
Price Target: $22
Current: $18.97
Upside: +15.97%
NNN REIT
Oct 1, 2024
Assumes: Equal-Weight
Price Target: $47 → $50
Current: $42.94
Upside: +16.44%
Ventas
Oct 1, 2024
Assumes: Overweight
Price Target: $61 → $71
Current: $64.84
Upside: +9.50%
Sabra Health Care REIT
Oct 1, 2024
Assumes: Overweight
Price Target: $16 → $20
Current: $19.67
Upside: +1.68%
National Health Investors
Oct 1, 2024
Assumes: Equal-Weight
Price Target: $81 → $86
Current: $81.09
Upside: +6.06%